{"prompt": "['Alliance A191402CD', 'TESTING DECISION AIDS TO IMPROVE PROSTATE CANCER DECISIONS FOR MINORITY MEN', 'Eligibility Criteria (see Section 3.2)', 'Required Initial Laboratory', 'Prostate biopsy within 4 months prior to registration showing', 'Values', 'newly diagnosed prostate cancer, stage T1-3N0 or X Mo or X (see $3.2.1)', 'In addition, patients must have:', 'PSA', '< 50 ng/mL', '- Gleason score 6-10', 'Patients who have had a history of non-cutaneous malignancy in the previous 5 years are not eligible.', 'Patients with history of non-melanoma skin cancer are eligible.', 'Scheduled prostate cancer consultation to be the first consultation after diagnosis (see $3.2.4)', 'Patients may not be concurrently enrolled to another clinical trial for the treatment of cancer. Co-', 'enrollment to biospecimen studies is allowed. Patients may be enrolled to other clinical trials after', 'completing all of the baseline interventions and measures.', 'Must be able to read and comprehend English (see $3.2.6)', 'Age > 18 years', 'Schema', 'Randomized', 'by institution', 'Pre- and During-consultation', 'R', 'Decision Aids1,2', 'E', 'G', 'Pre-consultation\u00b2', 'Baseline', 'I', 'Decision Aid Only', '12-Month', 'Questionnaires', 'S', 'Questionnaires and', 'given after', 'T', 'During-consultation\u00b9', 'Chart Review', 'Initial Visit', 'E', 'Decision Aid Only', 'R', 'Usual Care', '1', '\"Prostate Choice\" Decision Aid', '2', '\"Knowing Your Options\" Decision Aid', 'Please refer to the full protocol text for a complete description of the eligibility criteria and intervention', 'plan.', 'Site personnel will be trained on the delivery of the intervention prior to the enrollment of any patients. This', 'will consist of either video training and telephone conferencing or on-site training.', '4', 'Version Date: 11/30/2018', 'Update #06']['Alliance A191402CD', 'Table of Contents', 'Section', 'Page', '1.0', 'BACKGROUND', '7', '1.1', 'Significance and rationale', '7', '1.2', 'Study Goals', '11', '1.3', 'Significance', '11', '1.4', 'Description of Interventions to be tested', '11', '1.5', 'Design and Intervention Plan', '13', '2.0', 'OBJECTIVES', '15', '2.1', 'Primary objective', '15', '2.2', 'Secondary objectives', '15', '3.0', 'PATIENT SELECTION', '15', '3.1', 'On-Study Guidelines', '15', '3.2', 'Eligibility Criteria', '15', '4.0', 'PATIENT REGISTRATION', '16', '4.1', 'CTEP/DCP Registration Procedures', '16', '4.2', 'CTSU Registration Procedures', '16', '4.3', 'Patient Registration Requirements', '18', '4.4', 'Patient Registration/Randomization Procedures', '19', '4.5', 'Stratification and Treatment Assignments', '20', '5.0', 'STUDY CALENDAR', '21', '6.0', 'DATA AND SPECIMEN SUBMISSION', '22', '6.1', 'Data Collection and Submission', '22', '7.0', 'STUDY IMPLEMENTATION', '23', '7.1', 'Identification of participating institutions', '23', '7.2', 'Site training', '23', '7.3', 'Site scheduling and clinic space requirements', '23', '8.0', 'INTERVENTION', '24', '8.1', 'Patient identification, scheduling, and consent', '24', '8.2', 'Procedures for intervention on the day of the prostate cancer consult', '25', '8.3', '12-month follow up', '26', '9.0', 'ADVERSE EVENTS', '26', '10.0', 'MEASURES', '26', '10.1', 'Prostate Cancer Treatment Questionnaire (knowledge measure)', '26', '10.2', 'Decisional Conflict Scale (DCS)', '26', '10.3', 'Expanded Prostate Cancer Index Composite Short Form (EPIC-26)', '27', '10.4', 'Decisional Regret Scale', '27', '11.0', 'END OF INTERVENTION', '27', '11.1', 'Duration of Treatment', '27', '11.2', 'Managing ineligible patients and registered patients who never receive protocol intervention', '27', '11.3', 'Extraordinary Medical Circumstances', '27', '5', 'Version Date: 11/30/2018', 'Update #06']\n\n###\n\n", "completion": "END"}